Featuring the author Charles Calomiris, Henry Kaufman Professor of Financial Institutions, Columbia Business School; with comments by Andrew Olmem, Partner, Venable LLP; moderated by Mark Calabria, Director, Financial Regulation Studies, Cato Institute.
With the return of one-party government, major policy changes in health care seem all but inevitable. Yet fundamentally divergent interests in both Congress and the health industry will make consensus difficult to obtain. The most dangerous proposals are those that expand political control over patients’ health care decisions: mandates, price controls, and government-run health care for the middle class. How will centrists and market proponents recognize the forms these mistakes might take, and how can they defend against them? Please join Cato scholar Michael Cannon for an exploration of these and related issues.